NO942653L - Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient - Google Patents

Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient

Info

Publication number
NO942653L
NO942653L NO942653A NO942653A NO942653L NO 942653 L NO942653 L NO 942653L NO 942653 A NO942653 A NO 942653A NO 942653 A NO942653 A NO 942653A NO 942653 L NO942653 L NO 942653L
Authority
NO
Norway
Prior art keywords
estimating
carcinoma
patient
biopsy
potential
Prior art date
Application number
NO942653A
Other languages
English (en)
Norwegian (no)
Other versions
NO942653D0 (no
Inventor
Michael K Brawer
Original Assignee
Michael K Brawer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael K Brawer filed Critical Michael K Brawer
Publication of NO942653D0 publication Critical patent/NO942653D0/no
Publication of NO942653L publication Critical patent/NO942653L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
NO942653A 1992-01-15 1994-07-14 Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient NO942653L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112092A 1992-01-15 1992-01-15
PCT/US1993/000449 WO1993014407A1 (en) 1992-01-15 1993-01-15 A method for estimating the biologic potential of a selected carcinoma in a patient

Publications (2)

Publication Number Publication Date
NO942653D0 NO942653D0 (no) 1994-07-14
NO942653L true NO942653L (no) 1994-09-12

Family

ID=25232578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942653A NO942653L (no) 1992-01-15 1994-07-14 Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient

Country Status (11)

Country Link
US (2) US5688694A (de)
EP (1) EP0643839B1 (de)
JP (1) JPH07503069A (de)
AT (1) ATE145728T1 (de)
AU (1) AU673153B2 (de)
CA (1) CA2128031A1 (de)
DE (1) DE69306250T2 (de)
ES (1) ES2095038T3 (de)
FI (1) FI943355A (de)
NO (1) NO942653L (de)
WO (1) WO1993014407A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE431848T1 (de) * 1999-03-05 2009-06-15 Mitsubishi Rayon Co Microarray mit einer biologischen substanz
US6730313B2 (en) * 2000-01-25 2004-05-04 Edwards Lifesciences Corporation Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia
AU2002217821B2 (en) 2000-11-06 2007-12-13 Board Of Regents, The University Of Texas System Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
US6993175B2 (en) * 2001-09-07 2006-01-31 Quest Diagnostics Investments Incorporated Methods for measuring microvascular density in tumors
US7229423B2 (en) * 2003-02-05 2007-06-12 Timi 3 System, Inc Systems and methods for applying audible acoustic energy to increase tissue perfusion and/or vasodilation
US20070100335A1 (en) * 2005-10-28 2007-05-03 Apple Medical Corporation Instrument for electrosurgical excision procedure for the uterine cervix
WO2011028146A1 (ru) * 2009-09-04 2011-03-10 Korotkov Konstantin Georgievich Способ определения состояния биологического объекта и устройство для его реализации
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094028A1 (en) * 1990-10-16 1992-04-17 Bo E. Hedlund Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging

Also Published As

Publication number Publication date
AU673153B2 (en) 1996-10-31
ATE145728T1 (de) 1996-12-15
AU3478293A (en) 1993-08-03
ES2095038T3 (es) 1997-02-01
EP0643839A1 (de) 1995-03-22
EP0643839B1 (de) 1996-11-27
US5688694A (en) 1997-11-18
WO1993014407A1 (en) 1993-07-22
DE69306250T2 (de) 1997-03-20
CA2128031A1 (en) 1993-07-22
FI943355A0 (fi) 1994-07-14
FI943355A (fi) 1994-09-14
JPH07503069A (ja) 1995-03-30
NO942653D0 (no) 1994-07-14
US5616469A (en) 1997-04-01
DE69306250D1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
Paulson et al. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study
ITTO20010411A0 (it) Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti.
DE69906992D1 (de) Zweite medizinische indikation einer partikelverabreichungsmethode
EP2363477A3 (de) Verfahren zur Isolierung von RNA aus Formalin-fixierten Paraffin-eingebetteten Gewebeproben
NO964187L (no) Fremgangsmåte for fremstilling av mykobakterier
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
ATE223051T1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
NO942653D0 (no) Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient
BG97041A (bg) Проби на база протеин-нуклеинова киселина и метод за използването им при имуноизследване
EP0684471A3 (de) Vorrichtung zum Messen der Gesamtgehaltes an organischem Kohlenstoff
SE8701905L (sv) Foerfarande och kit foer diagnos av iga-nefropati
Bauer et al. Dissociative experiences and psychopathological symptomatology in a Scottish sample.
FR2810114B1 (fr) Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate
EP1191346A3 (de) Verfolgen der Spinresonanzfrequenz in der magnetischen Resonanz
ATE293794T1 (de) Verfahren zur diagnose von sepsis unter bestimmung von ca 125
NO980965L (no) En fremgangsmÕte for Õ fastslÕ oksygenkonsentrasjonen i en pr÷ve
AU3485393A (en) Immunological method for the detection of malignant tumours, and a kit for carrying out the method
CA2100464A1 (en) Prescreening of prostate cancer by serum prostatic specific antigen
EP1039394A3 (de) Verfahren und Anordnung zur Datenauswertung
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
PT1218749E (pt) Sistema de deteccao de cancro da prostata atraves da analise do psa/igf-l livre
ITBO980569A0 (it) Strumento ad ago per l' esecuzione di biopsie .
WO1993002217A3 (fr) Sondes oligonucleotidiques pour le typage et la detection des papillomavirus humains
Felmingham Sensitivity Testing and Mic Determination of Obligate Anaerobes
Balbi et al. Method for the Determination of Nonmetallic Inclusions